Literature DB >> 11377046

Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.

L Sek1, C J Porter, W N Charman.   

Abstract

The development of new and simple high performance thin layer chromatography (HPTLC) assays for the quantification of medium chain triglycerides (MCT, tricaprylin) and long chain triglycerides (LCT, triolein) and their lipolytic products, bile salts (BS) and phospholipids (PL) are described. Different classes of lipids (PL, BS, fatty acids, monoglycerides, diglycerides, and triglycerides) were separated on a single silica gel 60 HPTLC plate by Automated Multiple Development (AMD) methods using a Camag AMD 2. Post-chromatographic staining of long chain lipids (triolein, diolein, monoolein, and oleic acid), PL and BS with a solution of copper sulphate-phosphoric acid and medium chain lipids (tricaprylin, dicaprylin, monocaprylin, and caprylic acid) with a solution of ammonium molybdate-perchloric acid allowed visualisation of the lipids. Lipids were quantified by in situ spectrodensitometric measurements using a Camag TLC scanner 3. The intra- and inter-assay accuracy was between 83 and 115% and the assay was precise to within a CV of less than 20% over a range of 0.1-1 and 5-50 microg for long chain lipids and medium chain lipids, respectively. The methods have been employed to study the kinetics of triolein and tricaprylin lipolysis in an in vitro lipid digestion model commonly used to assess the digestibility of novel oral lipid-based formulations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377046     DOI: 10.1016/s0731-7085(00)00528-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  35 in total

1.  Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.

Authors:  Andrea Rübe; Sandra Klein; Karsten Mäder
Journal:  Pharm Res       Date:  2006-08-10       Impact factor: 4.200

2.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Dina Y Otify; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

4.  In vitro intestinal bioaccessibility of alkylglycerols versus triacylglycerols as vehicles of butyric acid.

Authors:  Diana Martín; María I Morán-Valero; Francisco J Señoráns; Guillermo Reglero; Carlos F Torres
Journal:  Lipids       Date:  2011-01-12       Impact factor: 1.880

5.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

6.  Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.

Authors:  Cordula Stillhart; Georgios Imanidis; Martin Kuentz
Journal:  Pharm Res       Date:  2013-02-28       Impact factor: 4.200

7.  Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.

Authors:  Ruyue Lian; Yi Lu; Jianping Qi; Yanan Tan; Mengmeng Niu; Peipei Guan; Fuqiang Hu; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2011-09-23       Impact factor: 3.246

8.  Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.

Authors:  Angel Tan; Andrew K Davey; Clive A Prestidge
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

9.  Biopharmaceutical modeling of drug supersaturation during lipid-based formulation digestion considering an absorption sink.

Authors:  Cordula Stillhart; Georgios Imanidis; Brendan T Griffin; Martin Kuentz
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

10.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.